Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ORGO
#2633
Organogenesis Holdings Inc. Class A Common Stock
3.210
0
-16.08%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-16.08%
Monthly Change
-18.94%
6 month change
-25.17%
Cambio anual
-25.17%
Cierres anteriores
3.825
0
Open
3.210
0
Bid
Ask
Low
3.210
0
High
3.210
0
Volumen
54
Markets
Acciones
Atención Sanitaria
ORGO
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
132.58 M
126.83 M
126.85 M
126.86 M
126.91 M
128.64 M
—
Valuation ratios
Enterprise value
284.83 M
270.28 M
438.04 M
391.22 M
471.82 M
572.68 M
1.87 B
Price to earnings ratio
-47.67
-320
-27
-28.15
-38.36
34.53
-58.98
Price to sales ratio
0.83
0.87
1.24
1.11
1.17
—
—
Price to cash flow ratio
27.18
29.66
22.85
7.56
8.86
65.45
104.71
Price to book ratio
0.35
1.6
0.54
0.47
0.55
2.25
3.8
Enterprise value to EBITDA ratio
43.07
21.9
9.56
8.65
13.8
—
—
Profitability ratios
Return on assets %
0.03
-0.06
0.04
0.02
0.04
-0.02
0.08
Return on equity %
0.04
-0.12
0.08
0.04
0.08
-0.04
0.16
Return on invested capital %
-1.02
-20.26
26.26
12.6
23.31
-15.76
46.41
Gross margin %
76.73
75.48
72.64
97.78
98.48
98.75
367.65
Operating margin %
5.42
-17.92
30.85
12.45
13.74
-6.81
50.24
EBITDA margin %
8.52
55.13
-26.88
-10.97
-0.83
18.09
-20.59
Net margin %
10.71
-24.17
21.74
9.3
14.3
-5.66
39.67
Liquidity ratios
Quick ratio
2.74
3.35
3.67
3.45
2.88
3.32
13.32
Current ratio
3.09
3.69
4.12
3.95
3.32
3.62
15.01
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.26
0.27
0.18
0.22
0.31
0.41
1.11
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.13
0
—
—
—
—
—
Long term debt to total equity ratio
0.2
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.02
0.08
0.16
0.26
-0.02
-0.3
0.09
EBIT per share
0.05
0.5
-0.21
-0.12
0.14
0.28
0.09
EBITDA per share
0.07
0.53
-0.18
-0.09
-0.01
0.31
0.03
Total debt per share
—
—
—
—
—
—
—
Cash per share
0.7
1.03
0.87
0.58
0.49
0.72
2.65
Net current asset value per share
1.78
2.17
2.12
2.05
2.29
2.78
9.25
Tangible book value per share
1.77
1.68
1.6
1.53
1.65
2.01
6.8
Working capital per share
1.2
1.58
1.61
1.53
1.6
2.01
6.75
Book value per share
2.08
2
1.92
1.84
1.95
2.3
8.02
Noticias
Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript
Organogenesis kazancı $0,02 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
Avista Healthcare Partners yatırım ekibinde üç önemli terfi açıkladı
Organogenesis Holdings, Canton tesislerinin kira sözleşmelerini 2032’ye kadar uzattı
Organogenesis Holdings extends leases for Canton facilities through 2032
Coupang and Regencell among market cap stock movers on Friday
CMS LCD kararı sonrası Organogenesis hissesi BTIG’de Alım notunu korudu
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision
Organogenesis hissesi diz artriti tedavisi için FDA başvurusunu başlattıktan sonra yükseldi
Organogenesis stock rises after initiating FDA application for knee arthritis treatment
Organogenesis diz artriti tedavisi için FDA’ya aşamalı başvuru sürecini başlattı
Organogenesis begins FDA rolling review for knee arthritis treatment